These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38313163)

  • 1. Utilizing dehydroepiandrosterone sulfate and its ratio for detecting mild autonomous cortisol excess in patients with adrenal incidentaloma.
    Al-Waeli D; Alidrisi H; Mansour A
    J Med Life; 2023 Oct; 16(10):1456-1461. PubMed ID: 38313163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An adrenal incidentaloma that had appeared to produce dehydroepiandrosterone-sulfate in excess before immunohistochemical study of the tumor.
    Yamamoto T; Kimura T; Kubo Y; Nakatsuka SI; Harada H; Suzuki T; Sasano H
    Endocr J; 2023 Jan; 70(1):43-46. PubMed ID: 36171143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
    Kim BJ; Kwak MK; Ahn SH; Kim JS; Lee SH; Koh JM
    Osteoporos Int; 2018 Oct; 29(10):2299-2307. PubMed ID: 29971455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of adrenal computed tomography in predicting the functionality of adrenal incidentaloma.
    Al-Waeli DK; Mansour AA; Haddad NS
    Niger Postgrad Med J; 2020; 27(2):101-107. PubMed ID: 32295940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
    Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC; Annamalai AK; Prankerd-Smith O; Freeman N; Vengopal K; Graggaber J; Koulouri O; Powlson AS; Shaw A; Halsall DJ; Gurnell M
    J Clin Endocrinol Metab; 2017 Mar; 102(3):786-792. PubMed ID: 27797672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas.
    Bernini GP; Argenio GF; Vivaldi MS; Moretti A; Miccoli P; Iacconi P; Magagna A; Salvetti A
    J Endocrinol Invest; 1998 Jun; 21(6):365-71. PubMed ID: 9699128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas).
    Osella G; Terzolo M; Borretta G; Magro G; Alí A; Piovesan A; Paccotti P; Angeli A
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1532-9. PubMed ID: 7989452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal incidentaloma, a five year experience.
    Terzolo M; Osella G; Alì A; Reimondo G; Borretta G; Magro GP; Luceri S; Paccotti P; Angeli A
    Minerva Endocrinol; 1995 Mar; 20(1):69-78. PubMed ID: 7651285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
    Nawata H; Higuchi K; Yanase T; Takayanagi R; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.
    Comlekci A; Yener S; Ertilav S; Secil M; Akinci B; Demir T; Kebapcilar L; Bayraktar F; Yesil S; Eraslan S
    Endocrine; 2010 Feb; 37(1):40-6. PubMed ID: 19882253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome.
    Kleiber H; Rey F; Temler E; Gomez F
    J Endocrinol Invest; 1991 Jun; 14(6):489-92. PubMed ID: 1663528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of steroid secretion in patients with adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Magro GP; Termine A; Paccotti P; Angeli A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):740-4. PubMed ID: 8636297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors.
    Bencsik Z; Szabolcs I; Kovács Z; Ferencz A; Vörös A; Kaszás I; Bor K; Gönczi J; Góth M; Kovács L; Dohán O; Szilágyi G
    J Clin Endocrinol Metab; 1996 May; 81(5):1726-9. PubMed ID: 8626824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease.
    El Asmar N; Rajpal A; Selman WR; Arafah BM
    J Clin Endocrinol Metab; 2018 Feb; 103(2):477-485. PubMed ID: 29244084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency.
    Sayyed Kassem L; El Sibai K; Chaiban J; Abdelmannan D; Arafah BM
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3655-62. PubMed ID: 22851486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.